233 related articles for article (PubMed ID: 23816514)
1. Clinical spectrum and treatment outcome of severe malaria caused by Plasmodium vivax in 18 children from northern India.
Gehlawat VK; Arya V; Kaushik JS; Gathwala G
Pathog Glob Health; 2013 Jun; 107(4):210-4. PubMed ID: 23816514
[TBL] [Abstract][Full Text] [Related]
2. UK malaria treatment guidelines 2016.
Lalloo DG; Shingadia D; Bell DJ; Beeching NJ; Whitty CJM; Chiodini PL;
J Infect; 2016 Jun; 72(6):635-649. PubMed ID: 26880088
[TBL] [Abstract][Full Text] [Related]
3. Azithromycin for treating uncomplicated malaria.
van Eijk AM; Terlouw DJ
Cochrane Database Syst Rev; 2011 Feb; 2011(2):CD006688. PubMed ID: 21328286
[TBL] [Abstract][Full Text] [Related]
4. Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison.
Ratcliff A; Siswantoro H; Kenangalem E; Maristela R; Wuwung RM; Laihad F; Ebsworth EP; Anstey NM; Tjitra E; Price RN
Lancet; 2007 Mar; 369(9563):757-765. PubMed ID: 17336652
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated malaria in Papua New Guinea.
Tavul L; Hetzel MW; Teliki A; Walsh D; Kiniboro B; Rare L; Pulford J; Siba PM; Karl S; Makita L; Robinson L; Kattenberg JH; Laman M; Oswyn G; Mueller I
Malar J; 2018 Oct; 17(1):350. PubMed ID: 30290825
[TBL] [Abstract][Full Text] [Related]
6. A trial of combination antimalarial therapies in children from Papua New Guinea.
Karunajeewa HA; Mueller I; Senn M; Lin E; Law I; Gomorrai PS; Oa O; Griffin S; Kotab K; Suano P; Tarongka N; Ura A; Lautu D; Page-Sharp M; Wong R; Salman S; Siba P; Ilett KF; Davis TM
N Engl J Med; 2008 Dec; 359(24):2545-57. PubMed ID: 19064624
[TBL] [Abstract][Full Text] [Related]
7. The use of artemether-lumefantrine for the treatment of uncomplicated Plasmodium vivax malaria.
Bassat Q
PLoS Negl Trop Dis; 2011 Dec; 5(12):e1325. PubMed ID: 22216359
[TBL] [Abstract][Full Text] [Related]
8. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
West African Network for Clinical Trials of Antimalarial Drugs (WANECAM)
Lancet; 2018 Apr; 391(10128):1378-1390. PubMed ID: 29606364
[TBL] [Abstract][Full Text] [Related]
9. Susceptibility of Plasmodium falciparum to artemisinins and Plasmodium vivax to chloroquine in Phuoc Chien Commune, Ninh Thuan Province, south-central Vietnam.
Phong NC; Chavchich M; Quang HH; San NN; Birrell GW; Chuang I; Martin NJ; Manh ND; Edstein MD
Malar J; 2019 Jan; 18(1):10. PubMed ID: 30654808
[TBL] [Abstract][Full Text] [Related]
10. Clinical efficacy of chloroquine versus artemether-lumefantrine for Plasmodium vivax treatment in Thailand.
Krudsood S; Tangpukdee N; Muangnoicharoen S; Thanachartwet V; Luplertlop N; Srivilairit S; Wilairatana P; Kano S; Ringwald P; Looareesuwan S
Korean J Parasitol; 2007 Jun; 45(2):111-4. PubMed ID: 17570973
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic efficacy of artemether-lumefantrine in uncomplicated falciparum malaria in India.
Valecha N; Srivastava P; Mohanty SS; Mittra P; Sharma SK; Tyagi PK; Pradhan K; Dev V; Singh R; Dash AP; Sharma YD
Malar J; 2009 May; 8():107. PubMed ID: 19454000
[TBL] [Abstract][Full Text] [Related]
12. Confirmed vivax resistance to chloroquine and effectiveness of artemether-lumefantrine for the treatment of vivax malaria in Ethiopia.
Yohannes AM; Teklehaimanot A; Bergqvist Y; Ringwald P
Am J Trop Med Hyg; 2011 Jan; 84(1):137-40. PubMed ID: 21212216
[TBL] [Abstract][Full Text] [Related]
13. Artemether-lumefantrine versus artemisinin-naphthoquine in Papua New Guinean children with uncomplicated malaria: a six months post-treatment follow-up study.
Laman M; Benjamin JM; Moore BR; Salib M; Tawat S; Davis WA; Siba PM; Robinson LJ; Davis TM
Malar J; 2015 Mar; 14():121. PubMed ID: 25889150
[TBL] [Abstract][Full Text] [Related]
14. Artemisinin-based combination therapy for treating uncomplicated malaria.
Sinclair D; Zani B; Donegan S; Olliaro P; Garner P
Cochrane Database Syst Rev; 2009 Jul; 2009(3):CD007483. PubMed ID: 19588433
[TBL] [Abstract][Full Text] [Related]
15. Clinical and epidemiological profiles of severe malaria in children from Delhi, India.
Kaushik JS; Gomber S; Dewan P
J Health Popul Nutr; 2012 Mar; 30(1):113-6. PubMed ID: 22524128
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of artemether/lumefantrine for the treatment of uncomplicated Plasmodium vivax and P. falciparum malaria in young children in Papua New Guinea.
Senn N; Rarau P; Manong D; Salib M; Siba P; Reeder JC; Rogerson SJ; Genton B; Mueller I
Clin Infect Dis; 2013 May; 56(10):1413-20. PubMed ID: 23403171
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of Plasmodium falciparum-specific rapid diagnostic tests for assessment of parasite clearance and detection of recurrent infections after artemisinin-based combination therapy.
Aydin-Schmidt B; Mubi M; Morris U; Petzold M; Ngasala BE; Premji Z; Björkman A; Mårtensson A
Malar J; 2013 Oct; 12():349. PubMed ID: 24079306
[TBL] [Abstract][Full Text] [Related]
18. Comparative efficacies of artemisinin combination therapies in Plasmodium falciparum malaria and polymorphism of pfATPase6, pfcrt, pfdhfr, and pfdhps genes in tea gardens of Jalpaiguri District, India.
Saha P; Guha SK; Das S; Mullick S; Ganguly S; Biswas A; Bera DK; Chattopadhyay G; Das M; Kundu PK; Ray K; Maji AK
Antimicrob Agents Chemother; 2012 May; 56(5):2511-7. PubMed ID: 22314538
[TBL] [Abstract][Full Text] [Related]
19. Gametocyte Clearance Kinetics Determined by Quantitative Magnetic Fractionation in Melanesian Children with Uncomplicated Malaria Treated with Artemisinin Combination Therapy.
Karl S; Laman M; Moore BR; Benjamin J; Koleala T; Ibam C; Kasian B; Siba PM; Waltmann A; Mueller I; Woodward RC; St Pierre TG; Davis TM
Antimicrob Agents Chemother; 2015 Aug; 59(8):4489-96. PubMed ID: 25987625
[TBL] [Abstract][Full Text] [Related]
20. A prospective comparative study of knowlesi, falciparum, and vivax malaria in Sabah, Malaysia: high proportion with severe disease from Plasmodium knowlesi and Plasmodium vivax but no mortality with early referral and artesunate therapy.
Barber BE; William T; Grigg MJ; Menon J; Auburn S; Marfurt J; Anstey NM; Yeo TW
Clin Infect Dis; 2013 Feb; 56(3):383-97. PubMed ID: 23087389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
